デフォルト表紙
市場調査レポート
商品コード
1646736

アルボウイルス検査の世界市場

Arbovirus Testing


出版日
ページ情報
英文 173 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
アルボウイルス検査の世界市場
出版日: 2025年01月31日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 173 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

アルボウイルス検査の世界市場は2030年までに18億米ドルに達する

2024年に13億米ドルと推定されるアルボウイルス検査の世界市場は、分析期間2024-2030年にCAGR 5.9%で成長し、2030年には18億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるELISAベースの検査は、CAGR 5.5%を記録し、分析期間終了までに10億米ドルに達すると予測されます。RT-PCRベースの検査分野の成長率は、分析期間中CAGR 6.3%と推定されます。

米国市場は3億3,030万米ドルと推定、中国はCAGR 9.0%で成長予測

米国のアルボウイルス検査市場は、2024年に3億3,030万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 9.0%で推移し、2030年には4億1,900万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.5%と4.5%と予測されています。欧州では、ドイツがCAGR 4.0%で成長すると予測されています。

世界のアルボウイルス検査市場- 主要動向と促進要因のまとめ

現代の公衆衛生においてアルボウイルス検査が重要な理由とは?

アルボウイルス(節足動物が媒介するウイルス)は、感染した蚊やマダニなどの節足動物に刺されることでヒトに感染し、世界中で公衆衛生上の重大な課題となっています。ジカ熱、デング熱、チクングニア、西ナイル・ウイルスなどの病気が、特に熱帯・亜熱帯地域で流行しつつある今、効果的なアルボウイルス検査の必要性はかつてないほど高まっています。これらのウイルスを早期かつ正確に検出することは、流行の抑制、治療の指導、予防策の実施に不可欠です。アルボウイルス検査には、PCR(ポリメラーゼ連鎖反応)のような分子生物学的手法、抗体を検出する血清学的検査、細胞培養でのウイルス分離など、さまざまな診断法が含まれています。これらの検査の重要性は、感染を確認し、さまざまなアルボウイルスを区別し、疫学サーベイランスのための重要なデータを提供する能力にあります。気候変動、都市化、世界の旅行の増加などの要因によって、アルボウイルス感染の世界の発生率が上昇するにつれ、これらの疾患の影響を軽減するための検査の役割は、公衆衛生の取り組みにおいてますます重要になってきています。

技術の進歩はアルボウイルス検査をどのように強化しているか?

技術の進歩は、アルボウイルス検査の能力と精度を大幅に向上させ、より迅速で信頼性の高い診断と、より優れたアウトブレイク管理を可能にしています。分子診断、特にリアルタイムPCRは、ウイルスRNAの迅速かつ特異性の高い検出を、しばしば数時間以内に行うことにより、アルボウイルス検査に革命をもたらしました。これらの技術により、近縁のウイルスを区別することが可能になり、複数のアルボウイルスが流行している地域では極めて重要です。さらに、次世代シーケンサー(NGS)は、アルボウイルスの同定と特性解析の強力なツールとして台頭してきており、ウイルスの遺伝学に関する詳細な洞察を提供し、新規株や新興株の検出に役立っています。また、携帯型検査機器やポイントオブケア検査機器の革新により、タイムリーな診断が重要な遠隔地や資源の限られた環境におけるアルボウイルス診断へのアクセスも拡大しています。これらの進歩は、データ分析におけるAIや機械学習の統合と相まって、アルボウイルス検査の精度と効率を向上させるだけでなく、より積極的な公衆衛生対応を可能にしています。

アルボウイルス検査の未来を形作る新たな動向とは?

いくつかの新たな動向がアルボウイルス検査の将来を形成しており、公衆衛生戦略、技術革新、環境要因の幅広い変化を反映しています。重要な動向のひとつは、ひとつのサンプルから複数の病原体を同時に検出できるマルチプレックス検査が重視されるようになっていることです。これは診断プロセスを合理化し、公衆衛生の意思決定のためのより包括的なデータを提供するためで、異なるアルボウイルスの共流行が一般的な地域では特に重要です。もう一つの重要な動向は、過去の感染をより正確に検出し、集団の免疫レベルを測定できる、感度と特異度が向上した血清学的検査の開発です。さらに、疾病サーベイランスのためのデジタルヘルスプラットフォームやモバイルアプリの利用拡大により、アルボウイルス症例の追跡と報告が強化され、アウトブレイクのリアルタイムモニタリングが容易になっています。また、気候や蚊の生息数の傾向などの環境データと診断データの統合も普及しつつあり、アルボウイルス感染拡大の予測モデリングが可能になっています。このような動向は、アルボウイルス検査分野の技術革新を促進し、世界の健康安全保障の重要な要素であり続けることを確実にしています。

アルボウイルス検査市場の成長を促進する要因は?

アルボウイルス検査市場の成長は、技術の進歩、公衆衛生のニーズの進化、環境の変化に沿ったいくつかの要因によって推進されています。第一に、特に気候変動や都市化の影響を受ける地域におけるアルボウイルス感染の世界の発生率の増加が、信頼性が高く拡張性のある検査ソリューションの需要を促進しています。第二に、分子診断学とポイントオブケア検査技術の進歩により、アルボウイルス検査の利用しやすさと効率が拡大し、臨床と現場の両方でより迅速で正確な診断が可能になっています。第三に、特に旅行や観光における予防的健康対策への意識の高まりと実施により、先制検査やサーベイランス・システムの需要が高まっています。さらに、媒介感染症対策に重点を置いた世界的な保健イニシアティブの拡大により、アルボウイルス検査インフラと調査への投資の増加が促進しています。これらの要因が、革新的な診断ツールの開発およびデジタルヘルス技術の統合の進行と相まって、アルボウイルス検査市場の力強い成長に拍車をかけており、新興感染症との世界の闘いにおける重要な要素として位置づけられています。

セグメント

検査タイプ(ELISAベース検査、RT-PCRベース検査);エンドユーザー(公衆衛生研究所、病院、診断センター、その他のエンドユーザー)

調査対象企業の例(注目の合計42社)

  • Alere, Inc.
  • Diamedix Corporation
  • Euroimmun AG
  • Focus Diagnostics, Inc.
  • IBL International GmbH
  • NovaTec Immundiagnostica GmbH
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP10361

Global Arbovirus Testing Market to Reach US$1.8 Billion by 2030

The global market for Arbovirus Testing estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. ELISA-based Tests, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$1.0 Billion by the end of the analysis period. Growth in the RT-PCR based Tests segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$330.3 Million While China is Forecast to Grow at 9.0% CAGR

The Arbovirus Testing market in the U.S. is estimated at US$330.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$419.0 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Arbovirus Testing Market - Key Trends and Drivers Summarized

Why Is Arbovirus Testing Crucial in Modern Public Health?

Arboviruses, or arthropod-borne viruses, are transmitted to humans through the bites of infected mosquitoes, ticks, and other arthropods, posing significant public health challenges worldwide. With diseases such as Zika, Dengue, Chikungunya, and West Nile Virus becoming more prevalent, especially in tropical and subtropical regions, the need for effective arbovirus testing has never been more critical. Early and accurate detection of these viruses is essential for controlling outbreaks, guiding treatment, and implementing preventive measures. Arbovirus testing encompasses a range of diagnostic methods, including molecular techniques like PCR (Polymerase Chain Reaction), serological tests to detect antibodies, and virus isolation in cell cultures. The importance of these tests lies in their ability to confirm infections, differentiate between various arboviruses, and provide critical data for epidemiological surveillance. As the global incidence of arbovirus infections rises, driven by factors such as climate change, urbanization, and increased global travel, the role of testing in mitigating the impact of these diseases is becoming increasingly central to public health efforts.

How Are Technological Advances Enhancing Arbovirus Testing?

Technological advances are significantly enhancing the capabilities and accuracy of arbovirus testing, enabling faster, more reliable diagnosis, and better outbreak management. Molecular diagnostics, particularly real-time PCR, have revolutionized arbovirus testing by offering rapid and highly specific detection of viral RNA, often within hours. These techniques allow for the differentiation of closely related viruses, which is crucial in regions where multiple arboviruses are endemic. Additionally, next-generation sequencing (NGS) is emerging as a powerful tool in the identification and characterization of arboviruses, providing detailed insights into viral genetics and aiding in the detection of novel or emerging strains. Innovations in portable and point-of-care testing devices are also expanding access to arbovirus diagnostics in remote or resource-limited settings, where timely diagnosis is critical. These advancements, coupled with the integration of AI and machine learning in data analysis, are not only improving the accuracy and efficiency of arbovirus testing but also enabling more proactive public health responses.

What Emerging Trends Are Shaping the Future of Arbovirus Testing?

Several emerging trends are shaping the future of arbovirus testing, reflecting broader changes in public health strategies, technological innovation, and environmental factors. One significant trend is the increasing emphasis on multiplex testing, which allows for the simultaneous detection of multiple pathogens from a single sample. This is particularly important in regions where co-circulation of different arboviruses is common, as it streamlines the diagnostic process and provides more comprehensive data for public health decision-making. Another important trend is the development of serological tests with improved sensitivity and specificity, which can more accurately detect past infections and measure population immunity levels. Additionally, the growing use of digital health platforms and mobile apps for disease surveillance is enhancing the tracking and reporting of arbovirus cases, facilitating real-time monitoring of outbreaks. The integration of environmental data, such as climate and mosquito population trends, with diagnostic data is also becoming more prevalent, enabling more predictive modeling of arbovirus spread. These trends are driving innovation in the field of arbovirus testing, ensuring that it remains a critical component of global health security.

What Factors Are Driving Growth in the Arbovirus Testing Market?

The growth in the arbovirus testing market is driven by several factors that align with technological advancements, evolving public health needs, and environmental changes. Firstly, the increasing global incidence of arbovirus infections, particularly in regions affected by climate change and urbanization, is propelling demand for reliable and scalable testing solutions. Secondly, advancements in molecular diagnostics and point-of-care testing technologies are expanding the accessibility and efficiency of arbovirus testing, enabling quicker and more accurate diagnosis in both clinical and field settings. Thirdly, the growing awareness and implementation of preventive health measures, particularly in travel and tourism, are driving demand for preemptive testing and surveillance systems. Additionally, the expansion of global health initiatives focused on combating vector-borne diseases is fostering increased investment in arbovirus testing infrastructure and research. These factors, combined with the ongoing development of innovative diagnostic tools and the integration of digital health technologies, are fueling robust growth in the arbovirus testing market, positioning it as a critical element in the global fight against emerging infectious diseases.

SCOPE OF STUDY:

The report analyzes the Arbovirus Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (ELISA-Based Tests, RT-PCR Based Tests); End-Use (Public Health Laboratory, Hospitals, Diagnostic Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Alere, Inc.
  • Diamedix Corporation
  • Euroimmun AG
  • Focus Diagnostics, Inc.
  • IBL International GmbH
  • NovaTec Immundiagnostica GmbH
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Arbovirus Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Arbovirus Infections Spurs Growth in Testing Demand
    • Advancements in Molecular Diagnostics Propel Innovation in Arbovirus Testing
    • Increasing Adoption of Multiplex Testing Strengthens Business Case for Advanced Diagnostics
    • Expansion of Point-of-Care Testing Solutions Drives Accessibility in Remote Areas
    • Growing Use of AI and Machine Learning in Data Analysis Enhances Testing Accuracy
    • Increasing Focus on Travel-Related Health Measures Expands Market Opportunities
    • Advancements in Serological Testing Drive Demand for Enhanced Immunity Monitoring
    • Here's How Portable Testing Devices Are Enhancing Response Capabilities in Epidemic Zones
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for ELISA-based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for ELISA-based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for ELISA-based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for RT-PCR based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for RT-PCR based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for RT-PCR based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Public Health Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Arbovirus Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Arbovirus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Arbovirus Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Arbovirus Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Arbovirus Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Arbovirus Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION